Petros Pharmaceuticals Announces Online Distribution for Lead ED Product With Lemonaid Health
Yahoo FinanceApr 25 10:20 ET
Petros Pharmaceuticals Announces Online Distribution for Lead ED Product With Lemonaid Health | NASDAQ:PTPI
Proactive InvestorsApr 24 11:47 ET
Express News | Petros Pharmaceuticals Inc: New Collaboration With Lemonaid Health
Moomoo 24/7Apr 23 09:18 ET
Express News | Petros Pharmaceuticals Inc: Expands Online Distribution for Prescription Stendra(R) (Avanafil) Through New Agreement With Lemonaid Health
Moomoo 24/7Apr 23 09:17 ET
Positive Outlook for Petros Pharmaceuticals: Buy Rating Affirmed Amidst FDA Advances and Promising Stendra Developments
TipRanksApr 17 12:25 ET
Petros Pharmaceuticals Receives Positive Response From FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (Avanafil)
NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. , a company focused on expanding
AccesswireApr 16 09:15 ET
Optimistic Outlook on Petros Pharmaceuticals With a Buy Rating Amid Strategic Shift and Promising Drug Developments
TipRanksApr 3 14:25 ET
FibroGen, Acorda Therapeutics, Enveric Biosciences Among Healthcare Movers
Seeking AlphaApr 3 10:00 ET
SOL, MESO and ACOR Among Pre-market Losers
Seeking AlphaApr 3 08:12 ET
Express News | Petros Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 EPS Results
Moomoo 24/7Apr 2 11:42 ET
Canopy Growth, Exact Sciences, Stereotaxis Among Healthcare Movers
Seeking AlphaApr 2 10:00 ET
Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (Avanafil) as It Pursues OTC Status
Nitrate patients subgroup demonstrated 100% correct self-selection when utilizing the web app technology with the drug facts label compared to 40% when using drug facts label alone (among 86% vs. 56%
AccesswireApr 2 09:15 ET
Petros Pharmaceuticals Q4 EPS $(2.17) Misses $(1.11) Estimate, Sales $364.25K Miss $1.55M Estimate
Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(2.17) per share which missed the analyst consensus estimate of $(1.11) by 95.5 percent. This is a 6.9 percent decrease over losses o
BenzingaApr 2 08:12 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
BenzingaApr 2 08:07 ET
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
Yahoo FinanceMar 19 09:00 ET
Petros Pharmaceuticals Partners With AI Firm for New OTC Medication
InvestingFeb 14 09:40 ET
Petros Pharmaceuticals Enters Into AI Licensing Agreement With Leading Multi-Billion-Dollar Software Provider
AI software expected to further enable Petros's efforts to make STENDRA the first ED product to be offered over the counterNEW YORK, NY / ACCESSWIRE / February 14, 2024 / Petros Pharmaceuticals, Inc.
AccesswireFeb 14 09:15 ET
MQ, ORMP and EXAI Are Among Pre Market Gainers
Seeking AlphaFeb 12 08:34 ET
PLUG, PXLW and ASMB Are Among Pre Market Gainers
Seeking AlphaJan 31 08:24 ET
Compugen, Iterum Therapeutics Among Healthcare Movers
Seeking AlphaJan 30 10:00 ET
No Data
No Data